Endosomal recycling inhibitors downregulate the androgen receptor and synergise with enzalutamide-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Endosomal recycling inhibitors downregulate the androgen receptor and synergise with enzalutamide

Published:2023-11-14 Issue: Volume: Page:
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Fletcher Kelsey A.,Alkurashi Mai H.,Lindsay Andrew J.

Funder

School of Biochemistry & Cell Biology, UCC

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10637-023-01407-x.pdf

Reference44 articles.

1. Tamburrino L, Salvianti F, Marchiani S et al (2012) Androgen receptor (AR) expression in prostate cancer and progression of the tumor: Lessons from cell lines, animal models and human specimens. Steroids 77:996–1001. https://doi.org/10.1016/J.STEROIDS.2012.01.008

2. Liu JM, Liu YP, Chuang HC et al (2020) Androgen deprivation therapy for prostate cancer and the risk of hematologic disorders. PLoS One 15. https://doi.org/10.1371/JOURNAL.PONE.0229263

3. Gunner C, Gulamhusein A, Rosario DJ (2016) The modern role of androgen deprivation therapy in the management of localised and locally advanced prostate cancer. J Clin Urol 9:24. https://doi.org/10.1177/2051415816654048

4. Helsen C, Van Den Broeck T, Voet A et al (2014) Androgen receptor antagonists for prostate cancer therapy. Endocr Relat Cancer 21:T105–T118. https://doi.org/10.1530/ERC-13-0545

5. Erdogan B, Kostek O, Bekirhacioglu M (2018) Enzalutamide in Prostate Cancer, A Review on Enzalutamide and cancer. Eurasian J Med Oncol 2:121–129. https://doi.org/10.14744/EJMO.2018.72098

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endosomal recycling inhibitors downregulate estrogen receptor-alpha and synergise with endocrine therapies;Breast Cancer Research and Treatment;2024-01-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3